<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T18:02:42Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4691055" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4691055</identifier>
        <datestamp>2016-01-06</datestamp>
        <setSpec>ijms</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="publisher-id">ijms</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Molecular Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1422-0067</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4691055</article-id>
              <article-id pub-id-type="pmcid">PMC4691055</article-id>
              <article-id pub-id-type="pmc-uid">4691055</article-id>
              <article-id pub-id-type="pmid">26633361</article-id>
              <article-id pub-id-type="pmid">26633361</article-id>
              <article-id pub-id-type="doi">10.3390/ijms161226108</article-id>
              <article-id pub-id-type="publisher-id">ijms-16-26108</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The Importance of Caveolin-1 as Key-Regulator of Three-Dimensional Growth in Thyroid Cancer Cells Cultured under Real and Simulated Microgravity Conditions</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Riwaldt</surname>
                    <given-names>Stefan</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-16-26108">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bauer</surname>
                    <given-names>Johann</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-16-26108">2</xref>
                  <xref rid="c1-ijms-16-26108" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pietsch</surname>
                    <given-names>Jessica</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-16-26108">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Braun</surname>
                    <given-names>Markus</given-names>
                  </name>
                  <xref ref-type="aff" rid="af3-ijms-16-26108">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Segerer</surname>
                    <given-names>Jürgen</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4-ijms-16-26108">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schwarzwälder</surname>
                    <given-names>Achim</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4-ijms-16-26108">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Corydon</surname>
                    <given-names>Thomas J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="af5-ijms-16-26108">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Infanger</surname>
                    <given-names>Manfred</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-16-26108">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Grimm</surname>
                    <given-names>Daniela</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-16-26108">1</xref>
                  <xref ref-type="aff" rid="af5-ijms-16-26108">5</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Cho</surname>
                    <given-names>William Chi-shing</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-ijms-16-26108"><label>1</label>Plastic, Aesthetic and Hand Surgery, Otto-von-Guericke University Clinic, Leipziger Str. 44, 39120 Magdeburg, Germany; <email>stefan.riwaldt@med.ovgu.de</email> (S.R.); <email>jessica.pietsch@med.ovgu.de</email> (J.P.); <email>manfred.infanger@med.ovgu.de</email> (M.I.); <email>dgg@biomed.au.dk</email> (D.G.)</aff>
              <aff id="af2-ijms-16-26108"><label>2</label>Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany</aff>
              <aff id="af3-ijms-16-26108"><label>3</label>Institute for Molecular Physiology and Biotechnology of Plants (IMBIO), Gravitational Biology Group, University of Bonn, Karlrobert-Kreiten-Str. 13, 53115 Bonn, Germany; <email>m.braun@dlr.de</email></aff>
              <aff id="af4-ijms-16-26108"><label>4</label>Airbus Defense and Space GmbH (ADS), Claude-Dornier-Straße, 88090 Immenstaad, Germany; <email>juergen.segerer@airbus.com</email> (J.S.); <email>achim.schwarzwaelder@airbus.com</email> (A.S.)</aff>
              <aff id="af5-ijms-16-26108"><label>5</label>Institute of Biomedicine, Aarhus University, Wilhelm Meyers Allé 4, 8000 Aarhus C, Denmark; <email>corydon@biomed.au.dk</email></aff>
              <author-notes>
                <corresp id="c1-ijms-16-26108"><label>*</label>Correspondence: <email>jbauer@biochem.mpg.de</email>; Tel.: +49-89-8578-3803</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>30</day>
                <month>11</month>
                <year>2015</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>12</month>
                <year>2015</year>
              </pub-date>
              <volume>16</volume>
              <issue>12</issue>
              <fpage>28296</fpage>
              <lpage>28310</lpage>
              <history>
                <date date-type="received">
                  <day>09</day>
                  <month>10</month>
                  <year>2015</year>
                </date>
                <date date-type="accepted">
                  <day>20</day>
                  <month>11</month>
                  <year>2015</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
                <copyright-year>2015</copyright-year>
                <license>
                  <license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>We recently demonstrated that the <italic>CAV1</italic> gene was down-regulated, when poorly differentiated thyroid FTC-133 cancer cells formed spheroids under simulated microgravity conditions. Here, we present evidence that the caveolin-1 protein is involved in the inhibition of spheroid formation, when confluent monolayers are exposed to microgravity. The evidence is based on proteins detected in cells and their supernatants of the recent spaceflight experiment: “NanoRacks-CellBox-Thyroid Cancer”. The culture supernatant had been collected in a special container adjacent to the flight hardware incubation chamber and stored at low temperature until it was analyzed by Multi-Analyte Profiling (MAP) technology, while the cells remaining in the incubation chamber were fixed by RNA<italic>later</italic> and examined by mass spectrometry. The soluble proteins identified by MAP were investigated in regard to their mutual interactions and their influence on proteins, which were associated with the cells secreting the soluble proteins and had been identified in a preceding study. A Pathway Studio v.11 analysis of the soluble and cell-associated proteins together with protein kinase C alpha (PRKCA) suggests that caveolin-1 is involved, when plasminogen enriched in the extracellular space is not activated and the vascular cellular adhesion molecule (VCAM-1) mediated cell–cell adhesion is simultaneously strengthened and activated PRKCA is recruited in caveolae, while the thyroid cancer cells do not form spheroids.</p>
              </abstract>
              <kwd-group>
                <kwd>international space station</kwd>
                <kwd>pathway studio</kwd>
                <kwd>plasminogen</kwd>
                <kwd>tissue factor</kwd>
                <kwd>VCAM-1</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec1-ijms-16-26108">
              <title>1. Introduction</title>
              <p>Poorly differentiated thyroid cancer (PDTC) types have a high risk of local recurrence and exert a missing or insufficient uptake of radioiodine [<xref rid="B1-ijms-16-26108" ref-type="bibr">1</xref>,<xref rid="B2-ijms-16-26108" ref-type="bibr">2</xref>,<xref rid="B3-ijms-16-26108" ref-type="bibr">3</xref>]. A progress of cancer in the course of therapy with polytope metastatic invasion is the indication for external beam irradiation and requires a systemic therapy, because the 10-year survival rate is lower than 15% [<xref rid="B4-ijms-16-26108" ref-type="bibr">4</xref>]. Cytostatic chemotherapeutic drugs have a significant toxicity and show only transient and limited response rates [<xref rid="B5-ijms-16-26108" ref-type="bibr">5</xref>]. Therefore, the development of new treatment strategies and the search of new target proteins are important topics.</p>
              <p>In our approach to this aim, we investigated <italic>in vitro</italic> the migration and aggregation behavior of human thyroid cells including primary tumor cells and cell lines [<xref rid="B6-ijms-16-26108" ref-type="bibr">6</xref>,<xref rid="B7-ijms-16-26108" ref-type="bibr">7</xref>,<xref rid="B8-ijms-16-26108" ref-type="bibr">8</xref>]. Thereby, we learned that culturing the cells above an agarose gel in a 96-well plate (liquid-overlay technique) challenged 3D spheroid formation but prevented monolayer formation [<xref rid="B6-ijms-16-26108" ref-type="bibr">6</xref>,<xref rid="B7-ijms-16-26108" ref-type="bibr">7</xref>,<xref rid="B9-ijms-16-26108" ref-type="bibr">9</xref>]. Moreover, we exposed subconfluent monolayers to real (spaceflight) or simulated microgravity (Random Positioning Machine (RPM)), 2D clinostat) [<xref rid="B8-ijms-16-26108" ref-type="bibr">8</xref>,<xref rid="B9-ijms-16-26108" ref-type="bibr">9</xref>,<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>]. Under both conditions, the cells separate into two populations of which one remains adherent to the TECAPEEK or plastic surface of the culture dishes, while the other one forms spherical aggregates (multicellular spheroids, MCS) or tubes, which were floating in the culture supernatant [<xref rid="B8-ijms-16-26108" ref-type="bibr">8</xref>,<xref rid="B9-ijms-16-26108" ref-type="bibr">9</xref>,<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>,<xref rid="B12-ijms-16-26108" ref-type="bibr">12</xref>,<xref rid="B13-ijms-16-26108" ref-type="bibr">13</xref>].</p>
              <p>Challenged by these observations, we became interested in genes and proteins, which might regulate the cellular transition from a two- to a three-dimensional type of growth. As the genetic background of primary cultures scattered very much due to different tumor donors required for the experiments, we used the thyroid cancer cell lines FTC-133 and ML-1 [<xref rid="B14-ijms-16-26108" ref-type="bibr">14</xref>,<xref rid="B15-ijms-16-26108" ref-type="bibr">15</xref>] to perform molecular studies on thyroid cells which had been exposed to real or simulated microgravity. A number of molecules were detected, which appear to be up- or down-regulated on the proteomic and/or genomic level, when cells were exposed to microgravity [<xref rid="B8-ijms-16-26108" ref-type="bibr">8</xref>,<xref rid="B9-ijms-16-26108" ref-type="bibr">9</xref>,<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>,<xref rid="B12-ijms-16-26108" ref-type="bibr">12</xref>,<xref rid="B16-ijms-16-26108" ref-type="bibr">16</xref>,<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>]. Differences in gene expression patterns and accumulation of proteins were observed, when control cells, which were incubated under normal laboratory conditions (1<italic>g</italic>-samples), were compared with cells forming spheroids under simulated or real microgravity. Our results nicely completed the studies of a number of other researchers evaluated and cited in [<xref rid="B13-ijms-16-26108" ref-type="bibr">13</xref>,<xref rid="B18-ijms-16-26108" ref-type="bibr">18</xref>].</p>
              <p>In addition, we recognized that exposing cells to microgravity did not only change the expression of single dispersed genes or proteins, because we repeatedly observed that groups of interacting genes or proteins were together up- or down-regulated under defined conditions [<xref rid="B16-ijms-16-26108" ref-type="bibr">16</xref>,<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>,<xref rid="B18-ijms-16-26108" ref-type="bibr">18</xref>,<xref rid="B19-ijms-16-26108" ref-type="bibr">19</xref>,<xref rid="B20-ijms-16-26108" ref-type="bibr">20</xref>]. This suggested that several members of whole signaling pathways are changed also in thyroid cells as it was described for lymphocytes, where the protein kinase A (PKA) had been shown to be involved in the loss of T-cell activation in altered gravity using the RPM [<xref rid="B21-ijms-16-26108" ref-type="bibr">21</xref>,<xref rid="B22-ijms-16-26108" ref-type="bibr">22</xref>] or for fibroblasts, whose microgravity-dependent regulation of various types of collagen and integrins affected MAPK intracellular signaling pathways [<xref rid="B23-ijms-16-26108" ref-type="bibr">23</xref>].</p>
              <p>Recently, we detected a group of proteins related to the extracellular matrix, when we determined the proteome of FTC-133 thyroid cells, which had been flown to the ISS (Cellbox-1 experiment) and were cultured there for 10 days [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. In contrast to FTC-133 cells exposed to microgravity in earlier experiments, the cells obtained after the Cellbox-1 mission had not formed spheroids during their stay in microgravity. The obvious reason for this failure was that their exposure to microgravity began after the cell monolayer had reached confluence [<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. Hence, the study suggested that FTC-133 cells form spheroids, when sub-confluent monolayers are exposed to microgravity [<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>], but the cells remain adherent, when confluent cell monolayers are exposed to microgravity conditions [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. The group of proteins mentioned above included caveolin-1. The <italic>CAV1</italic> mRNA was down-regulated during spheroid formation on devices simulating microgravity [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>].</p>
              <p>In this study, we determined the proteins of the supernatant of the FTC-133 cells, which did not form spheroids during the Cellbox-1 mission [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. The detected soluble proteins were analyzed by Pathway Studio v11 [<xref rid="B25-ijms-16-26108" ref-type="bibr">25</xref>] in regard to their mutual interaction and their effect on the above mentioned group of proteins associated with the cells, which secreted the supernatant proteins, while they did not form spheroids in microgravity. Plasminogen and caveolin-1 attracted special attention, as both have already been described to be involved in anchorage independent growth of cancer cells [<xref rid="B26-ijms-16-26108" ref-type="bibr">26</xref>,<xref rid="B27-ijms-16-26108" ref-type="bibr">27</xref>].</p>
            </sec>
            <sec id="sec2-ijms-16-26108">
              <title>2. Results and Discussion</title>
              <sec id="sec2dot1-ijms-16-26108">
                <title>2.1. Proteins in Cell Supernatants</title>
                <p>Cell-associated [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>] and secreted proteins of FTC-133 thyroid cancer cells were investigated, after the cells had been cultured in spaceflight experiment containers (<xref ref-type="fig" rid="ijms-16-26108-f001">Figure 1</xref>) either during the Cellbox-1 spaceflight to the ISS including a 10-day-stay on the ISS (r-μ<italic>g</italic>-samples) or in an ISS-like-environment in a ground laboratory room (1<italic>g</italic>-sample). The cells, which did not form spheroids in microgravity, were fixed with RNA<italic>later</italic> and conserved until a proteome analysis was possible, which revealed 29 proteins that have not been detected before in thyroid protein analyses [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>].</p>
                <fig id="ijms-16-26108-f001" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>(<bold>a</bold>) Cell suspensions prepared in six spaceflight experiment containers. They were flown to the ISS, and another set was kept on ground as 1<italic>g</italic>-controls; (<bold>b</bold>,<bold>c</bold>) The cell culture chambers of the experiment units containing cell monolayers fixed with RNA<italic>later</italic>.</p>
                  </caption>
                  <graphic xlink:href="ijms-16-26108-g001"/>
                </fig>
                <p>The supernatants were analyzed by the company Myriad RBM, Austin, TX, USA. The Human Inflammation MAP and the Human Kidney MAP were chosen for the investigation of cytokines. <xref ref-type="table" rid="ijms-16-26108-t001">Table 1</xref> gives an overview of the 54 proteins, analyzed by the two MAPs indicated above. Thirty-eight of the searched antigens were not detected. However, antibodies against 16 different proteins made their targets visible, although the values of two remained below the least detectable dose (LDD). They are indicated in <xref ref-type="table" rid="ijms-16-26108-t001">Table 1</xref>.</p>
                <p>IL-6 and IL-8, which are known to be involved in angiogenesis and metastasis in different types of cancer, influence the formation and growth of MCS established under 1<italic>g</italic>-conditions using the liquid-overlay technique [<xref rid="B9-ijms-16-26108" ref-type="bibr">9</xref>,<xref rid="B28-ijms-16-26108" ref-type="bibr">28</xref>]. They were clearly elevated in space compared with 1<italic>g</italic>-samples (IL-6: 4.46-fold; IL-8 3.65-fold). In addition, the release of IL-7 was significantly elevated in Space samples. Its role in relation to thyroid cancer is still not known. Elevated serum levels of IL-7 in conjunction with IL-6, IL-10 and IL-14 seem to indicate both benign and malignant thyroid disease [<xref rid="B29-ijms-16-26108" ref-type="bibr">29</xref>].</p>
                <p>In addition, vascular endothelial growth factor (VEGF) was significantly elevated 2.63-fold in Space. VEGF promotes neo-angiogenesis and tumor growth [<xref rid="B30-ijms-16-26108" ref-type="bibr">30</xref>,<xref rid="B31-ijms-16-26108" ref-type="bibr">31</xref>] and is therefore currently a hot topic in cancer therapy [<xref rid="B32-ijms-16-26108" ref-type="bibr">32</xref>,<xref rid="B33-ijms-16-26108" ref-type="bibr">33</xref>].</p>
                <p>Interestingly, the level of the VEGF secretion was 10-fold higher during the Shenzhou-8 space mission when FTC-133 cells formed large spheroids [<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>], as compared to the Cellbox-1 mission indicating that the highest amount of VEGF was released from FTC-133 cells, which grew in form of 3D aggregates. Moreover, eotaxin-1, osteopontin, NGAL and IL-17 were not released by the FTC-133 cells during the Cellbox-1 spaceflight, although they could be measured after the earlier Shenzhou-8 mission [<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>] as well as after a 72 h lasting growth under simulated microgravity [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>], when IL-7 was not found but spheroids were formed.</p>
                <table-wrap id="ijms-16-26108-t001" position="float">
                  <object-id pub-id-type="pii">ijms-16-26108-t001_Table 1</object-id>
                  <label>Table 1</label>
                  <caption>
                    <p>Proteins searched in supernatants of FTC-133 cells with the help of multi-analyte profiling (MAP) technology.</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Factor</th>
                        <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">LDD (pg/mL)</th>
                        <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">μ<italic>g</italic> ISS</th>
                        <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1<italic>g</italic></th>
                        <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Factor</th>
                        <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">LDD (pg/mL)</th>
                        <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">μ<italic>g</italic> ISS</th>
                        <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1<italic>g</italic></th>
                      </tr>
                      <tr>
                        <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(pg/mL)</th>
                        <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(pg/mL)</th>
                        <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(pg/mL)</th>
                        <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(pg/mL)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">AAT</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">58</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-10</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">0.66</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">A1M</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">35</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-12p40</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">18</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">A2M</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">170 <sup>+</sup></td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">267 ± 12.5 <sup>†</sup></td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">267 ± 12.5 <sup>†</sup></td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-12p70</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">6.7</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">B2M</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">58</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">1433 ± 309 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">887 ± 266</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-15</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">58</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">BDNF</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">5.2</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-17</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">0.42</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">CRP</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">4.2</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-18</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">4.7</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">4 ± 1 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">2 ± 0</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">Calbindin</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">940</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-23</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">80</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">CLU</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">2800</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">KIM-1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">3.2</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">Cystatin-C</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">20</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">357 ± 68 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">146 ± 34</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">MIP-1alpha</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">2.4</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">Eotaxin-1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">11</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">MIP-1 beta</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">3.5</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">16 ± 3 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">9 ± 2</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">Factor VII</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">480</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">MMP-3</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">6.6</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">107 ± 39 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">18 ± 4</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">FRTN</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">7.5</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">2633 ± 1597 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">970 ± 93</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">MMP-9</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">3500</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">Fibrinogen</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">43</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">MCP-1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">15</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">14 ± 1 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">10 ± 1</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">GM-CSF</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">3.5</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">8 ± 2 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">4 ± 0</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">NGAL</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">50</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">Haptoglobin</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">74</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">670 ± 432 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">13000 ± 1633</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">Osteopontin</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">400</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">ICAM-1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">560</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">SCF</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">17</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IFN-gamma</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">0.3</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">RANTES</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">0.28</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-1 alpha</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">0.78</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">THP</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">130</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-1 beta</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">0.46</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">TIMP-1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">6.1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">607 ± 69 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">217 ± 52</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-1 ra</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">TNF-alpha</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">5.2</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-2</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">5.7</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">TNF-beta</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">6.4</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-3</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">TNFR-2</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">1.6</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-4</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">8.4</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">TFF3</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">28</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-5</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">8.7</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">VCAM-1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">8</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">127 ± 17 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">52 ± 8</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-6</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">851 ± 241 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">191 ± 57</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">VEGF</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">4.7</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">561 ± 43 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">213 ± 26</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" rowspan="1" colspan="1">IL-7</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">6.1</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">22 ± 2 *</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">12 ± 4</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">VDBP</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">15</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                      <tr>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-8</td>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.56</td>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6153 ± 2136 *</td>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1727 ± 482</td>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vWF</td>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">780</td>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.d.</td>
                        <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.d.</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn>
                      <p>Values are given with mean ± SD; 1<italic>g</italic>, corresponding ground control; n.d., not detectable; * <italic>p</italic> &lt; 0.05 for space sample <italic>vs.</italic> corresponding 1<italic>g</italic>-ground control; LDD (Least Detectable Dose)-determined as the mean ± 3 standard deviations; <sup>†</sup> unit changed to ng/mL.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>We also detected the tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) 2.8-fold and MMP-3 5.94-fold enhanced in space samples compared to 1<italic>g</italic>-samples. This is in contrast to earlier results, when the MMP-3 secretion was found decreased on the RPM and after the Shenzhou-8 spaceflight [<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>]. It is known that the extracellular matrix (ECM) is very important for tissue maintenance and integrity [<xref rid="B34-ijms-16-26108" ref-type="bibr">34</xref>]. MMPs enzymes are involved in ECM degradation and play a role in cancer progression. Their activity is regulated by TIMPs [<xref rid="B35-ijms-16-26108" ref-type="bibr">35</xref>]. The role of TIMPs in tumor growth and metastasis is not entirely clear. There are reports of growth-suppressing as well as growth-supporting properties [<xref rid="B36-ijms-16-26108" ref-type="bibr">36</xref>]. The release of the vascular cellular adhesion molecule (VCAM-1) was elevated 2.44-fold in Space, whereas the soluble intercellular adhesion molecule (ICAM-1) was not detected in the supernatant of the FTC-133 cells, like during an earlier study [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>]. Both play an essential role in the process of thyroid cancer growth [<xref rid="B37-ijms-16-26108" ref-type="bibr">37</xref>]. Like IL-18, monocyte chemotactic protein 1 (MCP-1) was detected but remained below the LDD in r-μ<italic>g</italic>- and 1<italic>g</italic>-samples. After the Shenzhou-8 mission (10 days), FTC-133 cells released 8 pg/mL MCP-1 in the spaceflight 1<italic>g</italic>-sample and 6.15 pg/mL MCP-1 in r-μ<italic>g</italic>-samples [<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>], while under simulated microgravity an up-regulation of MCP-1 was observed in both RPM- and clinostat-samples of ML-1 cells compared with static 1<italic>g-</italic>control samples [<xref rid="B9-ijms-16-26108" ref-type="bibr">9</xref>]. Tanaka <italic>et al.</italic> [<xref rid="B38-ijms-16-26108" ref-type="bibr">38</xref>] had demonstrated that immunohistochemically staining of papillary thyroid tumor samples indicated a correlation of MCP-1 expression with aggressive behavior of this tumor.</p>
                <p>The macrophage inflammatory protein-1 beta (MIP-1β) was increased 1.77-fold in the Space sample, while MIP-1α was not detectable (<xref ref-type="table" rid="ijms-16-26108-t001">Table 1</xref>). Both forms show diverging signaling [<xref rid="B39-ijms-16-26108" ref-type="bibr">39</xref>]. Hence, it is of interest that we did not detect MIP-1α during the Shenzhou-8 spaceflight either, but when FTC-133 cells were cultured under conditions of simulated microgravity [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>]. Ferritin was elevated 2.7-fold in r-μg-samples of the FTC-133 cells compared to control samples. The importance of soluble ferritin is still unclear. An abnormal ferritin expression was detected in thyroid and other tumors [<xref rid="B40-ijms-16-26108" ref-type="bibr">40</xref>,<xref rid="B41-ijms-16-26108" ref-type="bibr">41</xref>]. The release of haptoglobin in space was significantly decreased compared to samples cultured on ground. Fan <italic>et al.</italic> showed that the level of haptoglobin alpha-1 chain (9190 Da) progressively increased with the clinical stages I, II, III and IV in papillary thyroid cancer [<xref rid="B42-ijms-16-26108" ref-type="bibr">42</xref>]. The cysteine proteinase inhibitor cystatin-C was 2.44-fold higher released in orbit than on Earth. Its release in the breast cancer tumor microenvironment reduces the proteolytic degradation of extracellular substrates at low pH [<xref rid="B43-ijms-16-26108" ref-type="bibr">43</xref>].</p>
                <p>In addition, alpha-2-macroglobulin (A2M) was clearly secreted by the thyroid cancer cells on Earth and in space, but the secretion level was not changed. Beta-2-microglobulin (B2M) was highly secreted by the FTC-133 cells (887 pg/mL; LDD was 58 pg/mL) and increased 1.62-fold in space. B2M is involved in biological processes like growth, survival, apoptosis, or metastasis of cancer cells and is currently considered to be a target of tumor treatment with antibodies [<xref rid="B44-ijms-16-26108" ref-type="bibr">44</xref>]. GM-CSF is twofold elevated in r-μ<italic>g</italic>-samples. A similar result was found after three days on the RPM [<xref rid="B9-ijms-16-26108" ref-type="bibr">9</xref>]. Interestingly, during the Shenzhou-8 mission in 2011 the secretion of GM-CSF was reduced [<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>] and also when FTC-133 cells were cultured on the 2D-clinostat [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>]. GM-CSF is used as an adjuvant in tumor vaccination. Its usefulness, however, is controversial [<xref rid="B45-ijms-16-26108" ref-type="bibr">45</xref>].</p>
                <p>Taken together the results of <xref ref-type="table" rid="ijms-16-26108-t001">Table 1</xref>, most of the detected cytokines were differently secreted during the Cellbox-1 space mission as compared to the earlier Shenzhou-8 mission. After the Cellbox-1 mission no spheroids were found, whereas during the Shenzhou-8 spaceflight and the accompanying RPM study [<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>] or in a microgravity simulation device comparison study [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>] multicellular spheroids were formed in all experiments. This suggests that a relationship may exist between the proteins detected in the supernatant and the behavior of the cells secreting these proteins during the Cellbox-1 mission, as different types of proteins or equal proteins at different quantities were released into the supernatants, when the FTC-133 cells formed spheroids during the Shenzhou-8 mission [<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>] and device comparison study [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>]. In addition, virtually all the proteins detected in the Cellbox-1 supernatants are of interest in cancer research and medicine.</p>
              </sec>
              <sec id="sec2dot2-ijms-16-26108">
                <title>2.2. Interaction of Proteins in Cell Supernatants</title>
                <p>Hence, we studied whether the soluble factors found in the supernatant could influence cellular sheering out of the monolayer under microgravity. For this purpose, we first investigated their mutual interaction by applying the Pathway Studio program. <xref ref-type="fig" rid="ijms-16-26108-f002">Figure 2</xref> shows the interaction of the secreted proteins at gene (a) and protein levels (b). It can be clearly recognized that all proteins detected belong to a network of mutual interaction. This is true when genes are emphasized (a) and also when proteins are investigated (b). In both cases, mutual up-regulation (+) is dominating.</p>
                <fig id="ijms-16-26108-f002" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>Relationships of the 16 proteins found in the supernatants of the Cellbox-1 experiments (see <xref ref-type="table" rid="ijms-16-26108-t001">Table 1</xref>). (<bold>a</bold>) Mutual genetic regulation (<bold>b</bold>) Interaction and regulation on the protein level (solid lines indicate binding; arrows indicate direct regulation).</p>
                  </caption>
                  <graphic xlink:href="ijms-16-26108-g002"/>
                </fig>
              </sec>
              <sec id="sec2dot3-ijms-16-26108">
                <title>2.3. Interaction of Supernatant and Cell Associated Proteins</title>
                <p>Secondly, we wanted to know whether members of the protein network shown in <xref ref-type="fig" rid="ijms-16-26108-f002">Figure 2</xref>B could have influence on the proteins detected in thyroid cancer cells by mass spectrometry [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>], when the FTC-133 cells did not form spheroids under microgravity. For this purpose, we entered these SwissProt numbers together in the Pathway Studio program: (i) SwissProt numbers of the proteins detected by the MAP technology as indicated in <xref ref-type="table" rid="ijms-16-26108-t001">Table 1</xref>; (ii) SwissProt numbers of the proteins detected earlier in thyroid cancer cells by mass spectrometry [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>] and (iii) SwissProt number of PRKCA coded by a gene which showed a slight but insignificant tendency of up-regulation in MCS [<xref rid="B12-ijms-16-26108" ref-type="bibr">12</xref>,<xref rid="B17-ijms-16-26108" ref-type="bibr">17</xref>]. This program revealed a network of proteins as shown in <xref ref-type="fig" rid="ijms-16-26108-f003">Figure 3</xref>, which comprises 10 of the soluble proteins found in the supernatant and eight of the cell associated proteins determined in the preceding proteome study. In addition, a possible link of the PRKCA protein into the network via caveolin-1 as well as three centers of interaction around A2M, plasminogen (PLG) and tissue factor (F3) became obvious.</p>
                <fig id="ijms-16-26108-f003" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <p>Network of interacting proteins: Lines show a kind of binding like it occurs e.g., when TIMP1 binds to the catalytic domain of MMP3 blocking its proteolytic site, arrows indicate regulation by direct interaction, <italic>i.e.</italic>, by binding which effects conformational or local changes of the target protein, (+) mean up-regulation. The protein names are arranged according to the cellular locations of proteins. Upper part: extracellular proteins, middle part: membrane proteins, lower part (PRKCA): intracellular proteins.</p>
                  </caption>
                  <graphic xlink:href="ijms-16-26108-g003"/>
                </fig>
                <p>The most central point of intersection of this network is plasminogen (PLG). This zymogen is the inactive form of the proteolytic serine enzyme plasmin, which facilitates cancer cell migration as well as spheroid formation [<xref rid="B26-ijms-16-26108" ref-type="bibr">26</xref>]. Its activation is tightly regulated by a number of activators and inhibitors [<xref rid="B46-ijms-16-26108" ref-type="bibr">46</xref>]. If plasmin is generated, it can activate more plasminogen creating a plasmin amplification spiral [<xref rid="B26-ijms-16-26108" ref-type="bibr">26</xref>]. Alpha-2-macroglobulin interrupts this loop by inactivating plasmin directly [<xref rid="B26-ijms-16-26108" ref-type="bibr">26</xref>,<xref rid="B47-ijms-16-26108" ref-type="bibr">47</xref>]. In the MAP analysis described, we found A2M for the first time, but still at low concentration (50% above LDD). Equal amounts of this soluble protein were secreted by cells in r-μ<italic>g</italic>- and 1<italic>g</italic>-samples, although more B2M, IL-6, IL-8 and VEGFA were found in supernatants of r-μ<italic>g</italic>-samples (<xref ref-type="table" rid="ijms-16-26108-t001">Table 1</xref>). Hence, its inhibitory influence on plasminogen activation may be equal under both conditions. In addition, TIMP-1 reduces activation of plasminogen by inhibiting plasminogen activators and metalloproteinases [<xref rid="B48-ijms-16-26108" ref-type="bibr">48</xref>]. It was enhanced in flown samples, but MMP-3 was enhanced even more. Therefore, the inhibition of PLG activation by TIMP1 in r-μ<italic>g</italic>- and 1<italic>g</italic>-samples cannot be estimated now. Furthermore, apolipoprotein B (APO-B) is inhibiting the fibrinolytic activity of plasminogen, <italic>i.e.</italic>, its activation [<xref rid="B49-ijms-16-26108" ref-type="bibr">49</xref>]. Its concentration could not be quantified in the MS analysis. However, the fact that it was only detectable, when FTC-133 cells did not form spheroids strongly points to its inhibitory effects.</p>
                <p>Tetranectin (CLEC3B) is also a member of the network. It binds to plasminogen and appears to function as an anchor or reservoir of this protein [<xref rid="B50-ijms-16-26108" ref-type="bibr">50</xref>]. Tetranectin bound to plasminogen inhibits also its binding to the extracellular matrix, where plasmin causes degradation [<xref rid="B51-ijms-16-26108" ref-type="bibr">51</xref>,<xref rid="B52-ijms-16-26108" ref-type="bibr">52</xref>]. F3 (tissue factor) exerts stimulatory effects on plasminogen activation [<xref rid="B53-ijms-16-26108" ref-type="bibr">53</xref>]. This effect is inhibited by complex formation with APO-B [<xref rid="B54-ijms-16-26108" ref-type="bibr">54</xref>]. Tissue factor resides in various compartments of a cell. At the cell surface, it is co-localized with caveolin-1 [<xref rid="B55-ijms-16-26108" ref-type="bibr">55</xref>]. Dependent on the kind of insertion in caveolae, caveolin-1 may expose the tissue factor to its pathway inhibitors [<xref rid="B56-ijms-16-26108" ref-type="bibr">56</xref>]. Hence, it seems that down-regulation of plasminogen activation during the Cellbox-1 spaceflight could have prevented spheroid formation [<xref rid="B26-ijms-16-26108" ref-type="bibr">26</xref>].</p>
                <p>Caveolin-1 also supports cell-cell adhesion via membrane-bound VCAM-1. If caveolin-1 expression is knocked down by siRNA, VCAM-dependent cell-cell adhesion is blocked [<xref rid="B57-ijms-16-26108" ref-type="bibr">57</xref>]. We only found the soluble version of VCAM-1 in the Cellbox-1 study. However, the finding indicates that VCAM-1 was highly expressed and even enhanced in the r-μ<italic>g</italic>-samples. Caveolin-1 also forms scaffolds, which regulate the activity of PRKCA by its appropriate insertion in caveolae [<xref rid="B58-ijms-16-26108" ref-type="bibr">58</xref>]. Taken together, the proteins shown in <xref ref-type="fig" rid="ijms-16-26108-f003">Figure 3</xref> appear to contribute in preventing spheroid formation under microgravity, when the cells have reached a complete confluence at exposure-start. Caveolin-1 appears to play a central role in this game.</p>
              </sec>
              <sec id="sec2dot4-ijms-16-26108">
                <title>2.4. Possible Mechanisms of the Inhibition of Spheroid Formation</title>
                <p>Therefore, we looked closer at caveolin-1 and searched through further proteins that may interact with it. Of these proteins, we selected those which were earlier detected in our microgravity research projects.</p>
                <p><xref ref-type="fig" rid="ijms-16-26108-f004">Figure 4</xref> indicates seven proteins, which might regulate spheroid formation and simultaneously can bind to caveolin-1. In this manuscript, we explain how caveolin-1 interacts with the tissue factor (F3) and may contribute together with TIMP1, A2M and APO-B to the inhibition of plasminogen activation so that plasmin is not accumulated to such a concentration that it could trigger spheroid formation, even when this process is supported by real microgravity [<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>,<xref rid="B26-ijms-16-26108" ref-type="bibr">26</xref>]. In addition, caveolin-1 strengthens the cell-cell adhesion mediated by VCAM-1 [<xref rid="B57-ijms-16-26108" ref-type="bibr">57</xref>]. Thereby, it may prevent the cells sheering out of the monolayer. VCAM-1 also interacts with integrin-alpha-5 (<xref ref-type="fig" rid="ijms-16-26108-f004">Figure 4</xref>). Interestingly, FTC-133 cells, in which integrin-alpha-5 was found in a preceding proteome study, form faster large spheroids than CGTH-W-1 thyroid cells, in which integrin-alpha-5 could not be detected [<xref rid="B59-ijms-16-26108" ref-type="bibr">59</xref>].</p>
                <fig id="ijms-16-26108-f004" position="float">
                  <label>Figure 4</label>
                  <caption>
                    <p>Proteins binding to and interacting with caveolin-1.</p>
                  </caption>
                  <graphic xlink:href="ijms-16-26108-g004"/>
                </fig>
                <p>In a preceding gene analysis with FTC-133 cells exposed to simulated microgravity, one part of the cells formed spheroids, while the other part continued to grow as monolayer. The <italic>CD44</italic> and <italic>ITGB1</italic> (integrin-beta-1) genes were only up-regulated within the population of adherent cells [<xref rid="B12-ijms-16-26108" ref-type="bibr">12</xref>]. Furthermore, <italic>CAV-1</italic> and <italic>CTGF</italic> genes exerting proteins related via integrin-beta-1 (<xref ref-type="fig" rid="ijms-16-26108-f004">Figure 4</xref>) were simultaneously down-regulated in those cells forming MCS [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>]. It remains to be determined whether these two genes are also down-regulated when confluent monolayers are exposed to simulated microgravity.</p>
                <p>Although the impact of caveolin-1 binding to CD36 and SERPINF1 still has to be investigated, it seems that caveolin-1 inhibits anchorage independent cell growth of cancer cells [<xref rid="B27-ijms-16-26108" ref-type="bibr">27</xref>] initiating several cascades of protein reactions. Further spaceflight experiments on up- and down-regulation of caveolin-1 appear to be worthwhile, because several studies in cancer research revealed a role of this protein in tumor cell development. In normal breast epithelial cell lines (12N, MCF10), but not in breast cancer cell lines like MCF7 or T47D, <italic>CAV</italic> mRNA and caveolin proteins were found [<xref rid="B60-ijms-16-26108" ref-type="bibr">60</xref>]. A similar observation was made for caveolin-1, when bronchial epithelial cell lines were compared with lung cancer cell lines [<xref rid="B61-ijms-16-26108" ref-type="bibr">61</xref>]. Furthermore, immunohistochemical analyses of human ovarian tissue specimens revealed expression of the protein in normal tissue but not in serous ovarian carcinomas [<xref rid="B62-ijms-16-26108" ref-type="bibr">62</xref>]. Interestingly, cancer cells lost their capability of anchorage independent growth, when expression of caveolin-1 was re-induced by suitable vectors [<xref rid="B60-ijms-16-26108" ref-type="bibr">60</xref>,<xref rid="B63-ijms-16-26108" ref-type="bibr">63</xref>]. Thus, the FTC-133 cells lost their capability to form spheroids, when caveolin-1 protein became detectable in these cells by mass spectrometry, after they had formed confluent monolayers [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. Hence, space experiments like the one described in this and a preceding paper [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>] could be a model to study a cancer suppressive role of caveolin-1.</p>
                <p>However, when caveolin-1 expression was studied immunohistochemically on paraffin-embedded bladder tumour sections of 89 patients, only specimens of nine patients with high-grade bladder cancer were caveolin-1-positive [<xref rid="B64-ijms-16-26108" ref-type="bibr">64</xref>]. This discrepancy might be explained considering that caveolin-1 not only is capable to strengthen the cell–cell- or cell–ECM binding e.g., via VCAM-1 or integrin-alpha-5 [<xref rid="B57-ijms-16-26108" ref-type="bibr">57</xref>,<xref rid="B59-ijms-16-26108" ref-type="bibr">59</xref>], but also scaffolds proteins involved in the Ca<sup>2+</sup> household. Thereby, it could participate in the Ca<sup>2+</sup> regulation [<xref rid="B65-ijms-16-26108" ref-type="bibr">65</xref>]. A Ca<sup>2+</sup> dependent protein, which binds to caveolin-1 is the protein kinase C-alpha [<xref rid="B66-ijms-16-26108" ref-type="bibr">66</xref>,<xref rid="B67-ijms-16-26108" ref-type="bibr">67</xref>] (<xref ref-type="fig" rid="ijms-16-26108-f003">Figure 3</xref>). It influences the cytoplasmic Ca<sup>2+</sup> oscillation [<xref rid="B68-ijms-16-26108" ref-type="bibr">68</xref>], whose frequency has effects on gene expression [<xref rid="B69-ijms-16-26108" ref-type="bibr">69</xref>]. As far as we know, an influence of Ca<sup>2+</sup> regulation on microgravity related, scaffold-free spheroid formation has not yet been described. Future studies may show, whether Ca<sup>2+</sup> regulation mediates the changes of the expression of the genes, whose products are involved in microgravity-dependent spheroid formation of thyroid cells [<xref rid="B70-ijms-16-26108" ref-type="bibr">70</xref>]. They could make spaceflight experiments on cancer cells even more meaningful.</p>
              </sec>
            </sec>
            <sec id="sec3-ijms-16-26108">
              <title>3. Experimental Section</title>
              <sec id="sec3dot1-ijms-16-26108">
                <title>3.1. Cell Cultures</title>
                <p>We cultured poorly differentiated human follicular thyroid cancer cells (FTC-133 cell line) in RPMI-1640 medium supplemented with 10% fetal calf serum (Merck Millipore, Berlin, Germany), penicillin (100 U/mL) and streptomycin (100 μg/mL; Merck Millipore) at 37 °C and 5% CO<sub>2</sub> as described earlier. We purchased the FTC-133 cells from the Health Protection Agency Culture Collections (HPACC; Salixbury, UK). Prior to use, 10<sup>6</sup> cells were suspended in freshly prepared culture medium until transferring them into an automated cell culture system constructed for spaceflights [<xref rid="B10-ijms-16-26108" ref-type="bibr">10</xref>].</p>
              </sec>
              <sec id="sec3dot2-ijms-16-26108">
                <title>3.2. Cellbox-1 Spaceflight Experiment</title>
                <p>The Cellbox-1 spaceflight experiment was carried out as described by Riwaldt <italic>et al.</italic> [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. Shortly after, the launch of the rocket took place on 18 April 2014 from KSC, Cape Canaveral, FL, USA. On 20 May 2014, the cells returned to Earth with the Dragon capsule. The Dragon capsule splashed down into the Pacific near by the Californian coastline. Afterwards, they were delivered to the Space Life Science Laboratories (SLSL), 505 Odyssey Way, Merritt Island, FL, USA [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>].</p>
                <p>The cells were prepared and treated as described recently [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. Five days before the rocket launch, we transferred 1 million thyroid cancer cells in each of the experiment containers. We sent six containers to real μ-gravity on board the ISS, whereas three containers, identically in construction, stayed in an ISS-like-environment in a ground laboratory. The cells, which had been sent to space were called r-μ<italic>g</italic>-samples, the ground controls were called 1<italic>g</italic>-samples. Due to a launch delay, a medium exchange became necessary two days before the planned launch date.</p>
              </sec>
              <sec id="sec3dot3-ijms-16-26108">
                <title>3.3. Cell Fixation and Medium Exchange</title>
                <p>Cell fixation and medium exchange were performed in ground and flight modules in exactly the same manner. The procedure was published in Riwaldt <italic>et al.</italic> [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. Then, after a total period of 12 days, the pumps integrated in the space-suitable incubation modules worked automatically, replacing the used medium by new medium. Used medium was stored for supernatant analysis. The next step was the cell fixation of FTC-133-cells by RNA<italic>later</italic> with the help of the automatically working pump.</p>
              </sec>
              <sec id="sec3dot4-ijms-16-26108">
                <title>3.4. Cytokine Measurements by MAP-Technology</title>
                <p>In order to investigate the release of cytokines, we used Multi-Analyte Profiling (MAP) as previously described [<xref rid="B11-ijms-16-26108" ref-type="bibr">11</xref>,<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>]. The MAP-analyses were performed by the company Myriad RBM (Austin, TX, USA). Cell supernatants were investigated with the Human InflammationMAP<sup>®</sup> and Human KidneyMAP<sup>®</sup>.</p>
              </sec>
              <sec id="sec3dot5-ijms-16-26108">
                <title>3.5. Pathway Studio Analysis</title>
                <p>Pathway Studio v11 was purchased from Elsevier Research Solutions, Amsterdam, The Netherlands. This program was used online [<xref rid="B25-ijms-16-26108" ref-type="bibr">25</xref>]. To start an analysis, the SwissProt numbers of the proteins of interest were entered.</p>
              </sec>
              <sec id="sec3dot6-ijms-16-26108">
                <title>3.6. Statistical Evaluation</title>
                <p>SPSS<sup>®</sup> Statistics 23.0 was used for statistical evaluation. Detected cytokine concentration was compared for 1<italic>g</italic> and r-μ<italic>g</italic> using one-way ANOVA. All data are presented as mean ± standard deviation (SD). The significance level was set by <italic>p</italic> &lt; 0.05, * indicating significant differences.</p>
              </sec>
            </sec>
            <sec id="sec4-ijms-16-26108">
              <title>4. Conclusions</title>
              <p>From our results, we conclude that inhibition of spheroid formation under microgravity and inhibition of anchorage independent growth of various types of cancer cells on the ground proceed via similar pathways [<xref rid="B24-ijms-16-26108" ref-type="bibr">24</xref>,<xref rid="B26-ijms-16-26108" ref-type="bibr">26</xref>,<xref rid="B27-ijms-16-26108" ref-type="bibr">27</xref>]. In both cases, plasminogen and caveolin-1 appear to play a key role. At least concerning the inhibition of spheroid formation under microgravity VCAM, tissue factor, alpha-2-macroglobulin, apolipoprotein B, tissue inhibitor of metalloproteinases-1 and protein kinase C alpha seem to be further members of relevant pathways, like those which regulate plasminogen activation or cell–cell adhesion.</p>
              <p>In addition, our approach to focus on proteins, which become detectable only after special treatment, led to valuable information.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>The study was funded by the German Space Administration (DLR) on behalf of the Bundesministerium für Wirtschaft und Energie (BMWi grants 50WB0824, 50WB1124 and 50WB1524) (Daniela Grimm). The authors would like to thank Professor Albert Sickmann from the ISAS, Dortmund, Germany, for his continuous support of our microgravity project as well as Guenter Ruyters and Peter Preu from the DLR Space Administration, Bonn, Germany, for giving us the opportunity to participate in this SPACEX CRS-3 Mission. The help of Markus Bussen from the Elsevier Information Systems GmbH, Frankfurt, Germany in application of the Pathway Studio is highly appreciated.</p>
            </ack>
            <notes>
              <title>Author Contributions</title>
              <p>Daniela Grimm, Manfred Infanger, Jessica Pietsch and Johann Bauer conceived and designed the experiments; Jessica Pietsch, Stefan Riwaldt, Markus Braun and Daniela Grimm performed the experiments; Jürgen Segerer and Achim Schwarzwälder prepared the Space suitable hardware; Daniela Grimm and Johann Bauer analyzed the data; Stefan Riwaldt, Daniela Grimm, Thomas J. Corydon and Johann Bauer wrote the paper.</p>
            </notes>
            <notes>
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest.</p>
            </notes>
            <glossary>
              <title>Abbreviations</title>
              <array>
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">μ<italic>g</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Microgravity</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1<italic>g</italic>-samples</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cells treated and incubated on ground equally as the space-flown cells</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">r-μ<italic>g</italic>-samples</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cells flown to the ISS</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2D</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Two-dimensional</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3D</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Three-dimensional</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">A2M</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Alpha-2-macroglobulin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ANOVA</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Analysis of variance</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">APO-B</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Apolipoprotein B</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">B2M</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Beta-2-microglobulin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CAV</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Caveolin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CCL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">C-C motif chemokine</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CD</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cluster of differentiation</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CD36</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Platelet glycoprotein 4</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CLEC3B</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Tetranectin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CSF</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Colony-stimulating factor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CTGF</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Connective Tissue Growth Factor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">DLR</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Deutsches Zentrum für Luft- und Raumfahrt, German Space Agency</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ECM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Extracellular matrix</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">F2</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Prothrombin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">F3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Thromboplastin, tissue factor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">F3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Tissue factor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">FTC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Follicular thyroid cancer</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">FTH</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Ferritin heavy chain</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">GM-CSF</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Granulocyte-macrophage-colony-stimulating factor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">HP</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Haptoglobin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">IL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Interleukin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ISS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">International Space Station</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ITGB</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Integrin beta</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">KSC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Kennedy Space Center</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">LDD</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Lowest detectable dose</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MAP</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Multianalyte Profiling</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MAP<sup>®</sup></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Multi-Analyte Profiling</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MAPK</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Mitogen-activated protein kinase</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MCP-1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Monocyte chemotactic protein 1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MCS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Multicellular spheroids</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MIP-1ß</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Macrophage inflammatory Protein 1 beta</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MMP-3</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Matrix metalloproteinase 3</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">NASA</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">National Aeronautic and Space Administration</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">NGAL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Neutrophil gelatinase-associated lipocalin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PDTC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Poorly differentiated thyroid cancer</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PDTC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Poorly differentiated thyroid cancer cells</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PKA</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Protein kinase A</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PRKCA</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Protein kinase C alpha</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PLG</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Plasminogen</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RPM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Random Positioning Machine</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RPMI</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Roswell Park Memorial Institute medium</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SD</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Standard deviation</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SERPIN</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Serin protease inhibitor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SLSL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Space Live Science laboratories</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SPSS<sup>®</sup></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Statistical Package for the Social Sciences</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">TIMP-1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Tissue inhibitor of matrix metalloproteinase 1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">VCAM-1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Vascular cellular adhesion molecule-1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">VEGF</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Vascular endothelial growth factor</td>
                  </tr>
                </tbody>
              </array>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="B1-ijms-16-26108">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vigneri</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Malandrino</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Vigneri</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>The changing epidemiology of thyroid cancer: Why is incidence increasing?</article-title>
                  <source>Curr. Opin. Oncol.</source>
                  <year>2015</year>
                  <volume>27</volume>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1097/CCO.0000000000000148</pub-id>
                  <?supplied-pmid 25310641?>
                  <pub-id pub-id-type="pmid">25310641</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-ijms-16-26108">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Pohl</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Magnusson</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms of apoptosis in irradiated and sunitinib-treated follicular thyroid cancer cells</article-title>
                  <source>Apoptosis</source>
                  <year>2014</year>
                  <volume>19</volume>
                  <fpage>480</fpage>
                  <lpage>490</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10495-013-0937-0</pub-id>
                  <?supplied-pmid 24213562?>
                  <pub-id pub-id-type="pmid">24213562</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-ijms-16-26108">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Pohl</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Magnusson</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of sunitinib on human thyroid cancer cells</article-title>
                  <source>Cell. Physiol. Biochem.</source>
                  <year>2013</year>
                  <volume>32</volume>
                  <fpage>154</fpage>
                  <lpage>170</lpage>
                  <pub-id pub-id-type="doi">10.1159/000350132</pub-id>
                  <?supplied-pmid 23867310?>
                  <pub-id pub-id-type="pmid">23867310</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-ijms-16-26108">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Durante</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Haddy</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Baudin</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Leboulleux</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Hartl</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Travagli</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Caillou</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Ricard</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Lumbroso</surname>
                      <given-names>J.D.</given-names>
                    </name>
                    <name>
                      <surname>de Vathaire</surname>
                      <given-names>F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2006</year>
                  <volume>91</volume>
                  <fpage>2892</fpage>
                  <lpage>2899</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2005-2838</pub-id>
                  <?supplied-pmid 16684830?>
                  <pub-id pub-id-type="pmid">16684830</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-ijms-16-26108">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baudin</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Schlumberger</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>New therapeutic approaches for metastatic thyroid carcinoma</article-title>
                  <source>Lancet Oncol.</source>
                  <year>2007</year>
                  <volume>8</volume>
                  <fpage>148</fpage>
                  <lpage>156</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1470-2045(07)70034-7</pub-id>
                  <pub-id pub-id-type="pmid">17267329</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-ijms-16-26108">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kromer</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Steinbach</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Riegger</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Hofstadter</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Human follicular and papillary thyroid carcinoma cells interact differently with human venous endothelial cells</article-title>
                  <source>Thyroid</source>
                  <year>1995</year>
                  <volume>5</volume>
                  <fpage>155</fpage>
                  <lpage>164</lpage>
                  <?supplied-pmid 7580262?>
                  <pub-id pub-id-type="pmid">7580262</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-ijms-16-26108">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hofstadter</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Riegger</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Kromer</surname>
                      <given-names>E.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Characteristics of multicellular spheroids formed by primary cultures of human thyroid tumor cells</article-title>
                  <source>Thyroid</source>
                  <year>1997</year>
                  <volume>7</volume>
                  <fpage>859</fpage>
                  <lpage>865</lpage>
                  <pub-id pub-id-type="doi">10.1089/thy.1997.7.859</pub-id>
                  <?supplied-pmid 9459629?>
                  <pub-id pub-id-type="pmid">9459629</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-ijms-16-26108">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kossmehl</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Shakibaei</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schoberger</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Pickenhahn</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Schulze-Tanzil</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Vetter</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Paul</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells</article-title>
                  <source>FASEB J.</source>
                  <year>2002</year>
                  <volume>16</volume>
                  <fpage>604</fpage>
                  <lpage>606</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.01-0673fje</pub-id>
                  <?supplied-pmid 11919168?>
                  <pub-id pub-id-type="pmid">11919168</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-ijms-16-26108">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Svejgaard</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sahana</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Hauslage</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Common effects on cancer cells exerted by a random positioning machine and a 2d clinostat</article-title>
                  <source>PLoS ONE</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <fpage>e0135157</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0135157</pub-id>
                  <?supplied-pmid 26274317?>
                  <pub-id pub-id-type="pmid">26274317</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-ijms-16-26108">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Schwarzwalder</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Segerer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Birlem</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Horn</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Spheroid formation of human thyroid cancer cells in an automated culturing system during the shenzhou-8 space mission</article-title>
                  <source>Biomaterials</source>
                  <year>2013</year>
                  <volume>34</volume>
                  <fpage>7694</fpage>
                  <lpage>7705</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.06.054</pub-id>
                  <?supplied-pmid 23866977?>
                  <pub-id pub-id-type="pmid">23866977</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-ijms-16-26108">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gorog</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Sahana</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Spheroid formation of human thyroid cancer cells under simulated microgravity: A possible role of ctgf and cav1</article-title>
                  <source>Cell Commun. Signal.</source>
                  <year>2014</year>
                  <volume>12</volume>
                  <fpage>32</fpage>
                  <pub-id pub-id-type="doi">10.1186/1478-811X-12-32</pub-id>
                  <?supplied-pmid 24885050?>
                  <pub-id pub-id-type="pmid">24885050</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-ijms-16-26108">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Saar</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hubner</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Abou-El-Ardat</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Baatout</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids</article-title>
                  <source>FASEB J.</source>
                  <year>2012</year>
                  <volume>26</volume>
                  <fpage>5124</fpage>
                  <lpage>5140</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.12-215749</pub-id>
                  <?supplied-pmid 22964303?>
                  <pub-id pub-id-type="pmid">22964303</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-ijms-16-26108">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>van Loon</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ulbrich</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Magnusson</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Growing tissues in real and simulated microgravity: New methods for tissue engineering</article-title>
                  <source>Tissue Eng. A</source>
                  <year>2014</year>
                  <volume>20</volume>
                  <fpage>555</fpage>
                  <lpage>566</lpage>
                  <pub-id pub-id-type="doi">10.1089/ten.teb.2013.0704</pub-id>
                  <?supplied-pmid 24597549?>
                  <pub-id pub-id-type="pmid">24597549</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-ijms-16-26108">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goretzki</surname>
                      <given-names>P.E.</given-names>
                    </name>
                    <name>
                      <surname>Frilling</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Simon</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Roeher</surname>
                      <given-names>H.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Growth regulation of normal thyroids and thyroid tumors in man</article-title>
                  <source>Recent Results Cancer Res.</source>
                  <year>1990</year>
                  <volume>118</volume>
                  <fpage>48</fpage>
                  <lpage>63</lpage>
                  <?supplied-pmid 2173080?>
                  <pub-id pub-id-type="pmid">2173080</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-ijms-16-26108">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schönberger</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Spruß</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Chahoud</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Establishment and characterization of the follicular thyroid carcinoma cell line ML-1</article-title>
                  <source>J. Mol. Med.</source>
                  <year>2000</year>
                  <volume>78</volume>
                  <fpage>102</fpage>
                  <lpage>110</lpage>
                  <pub-id pub-id-type="doi">10.1007/s001090000085</pub-id>
                  <?supplied-pmid 10794546?>
                  <pub-id pub-id-type="pmid">10794546</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-ijms-16-26108">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Riwaldt</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sickmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Interaction of proteins identified in human thyroid cells</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2013</year>
                  <volume>14</volume>
                  <fpage>1164</fpage>
                  <lpage>1178</lpage>
                  <pub-id pub-id-type="doi">10.3390/ijms14011164</pub-id>
                  <?supplied-pmid 23303277?>
                  <pub-id pub-id-type="pmid">23303277</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-ijms-16-26108">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Saar</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hubner</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schwarzwalder</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Segerer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space</article-title>
                  <source>FASEB J.</source>
                  <year>2014</year>
                  <volume>28</volume>
                  <fpage>813</fpage>
                  <lpage>835</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.13-243287</pub-id>
                  <?supplied-pmid 24196587?>
                  <pub-id pub-id-type="pmid">24196587</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-ijms-16-26108">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Richter</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Strauch</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Lebert</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Magnusson</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <name>
                      <surname>Wise</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of microgravity based proeomics research</article-title>
                  <source>Expert Rev. Proteom.</source>
                  <year>2014</year>
                  <volume>11</volume>
                  <fpage>465</fpage>
                  <lpage>476</lpage>
                  <pub-id pub-id-type="doi">10.1586/14789450.2014.926221</pub-id>
                  <?supplied-pmid 24957700?>
                  <pub-id pub-id-type="pmid">24957700</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-ijms-16-26108">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Sickmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wildgruber</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Strauch</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Proteomic differences between microvascular endothelial cells and EA.hy926 cell line forming three-diesnional structures</article-title>
                  <source>Proteomics</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <fpage>689</fpage>
                  <lpage>698</lpage>
                  <pub-id pub-id-type="doi">10.1002/pmic.201300453</pub-id>
                  <?supplied-pmid 24376074?>
                  <pub-id pub-id-type="pmid">24376074</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-ijms-16-26108">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schulz</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Saar</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hubner</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Gebomic approach to identify factors that drive the formation of three-dimensional structures by EA.hy926 endothelial cells</article-title>
                  <source>PLoS ONE</source>
                  <year>2013</year>
                  <volume>8</volume>
                  <fpage>e64402</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0064402</pub-id>
                  <?supplied-pmid 23675535?>
                  <pub-id pub-id-type="pmid">23675535</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-ijms-16-26108">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>T.T.</given-names>
                    </name>
                    <name>
                      <surname>Walther</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.F.</given-names>
                    </name>
                    <name>
                      <surname>Boonyaratanakornkit</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Galleri</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Meloni</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Pippia</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Cogoli</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hughes-Fulford</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Rel/NF-kappa B pathway and transcription of immediate early genes in T cell activation are inhibited by microgravity</article-title>
                  <source>J. Leukoc. Biol.</source>
                  <year>2012</year>
                  <volume>92</volume>
                  <fpage>1133</fpage>
                  <lpage>1145</lpage>
                  <pub-id pub-id-type="doi">10.1189/jlb.0312157</pub-id>
                  <?supplied-pmid 22750545?>
                  <pub-id pub-id-type="pmid">22750545</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-ijms-16-26108">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boonyaratanakornkit</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Cogoli</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.F.</given-names>
                    </name>
                    <name>
                      <surname>Schopper</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Pippia</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Galleri</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Meloni</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Hughes-Fulford</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Key gravity-sensitive signaling pathways drive t cell activation</article-title>
                  <source>FASEB J.</source>
                  <year>2005</year>
                  <volume>19</volume>
                  <fpage>2020</fpage>
                  <lpage>2022</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.05-3778fje</pub-id>
                  <?supplied-pmid 16210397?>
                  <pub-id pub-id-type="pmid">16210397</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-ijms-16-26108">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Loesberg</surname>
                      <given-names>W.A.</given-names>
                    </name>
                    <name>
                      <surname>Walboomers</surname>
                      <given-names>X.F.</given-names>
                    </name>
                    <name>
                      <surname>van Loon</surname>
                      <given-names>J.J.W.A.</given-names>
                    </name>
                    <name>
                      <surname>Jansen</surname>
                      <given-names>J.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity activates MAPK pathways in fibroblasts cultured on microgrooved surface topography</article-title>
                  <source>Cell Motil. Cytoskelet.</source>
                  <year>2008</year>
                  <volume>65</volume>
                  <fpage>116</fpage>
                  <lpage>129</lpage>
                  <pub-id pub-id-type="doi">10.1002/cm.20248</pub-id>
                  <?supplied-pmid 17987657?>
                  <pub-id pub-id-type="pmid">17987657</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-ijms-16-26108">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Riwaldt</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sickmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Segerer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schwarzwalder</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Identification of proteins involved in inhibition of spheroid formation under microgravity</article-title>
                  <source>Proteomics</source>
                  <year>2015</year>
                  <volume>15</volume>
                  <fpage>2945</fpage>
                  <lpage>2952</lpage>
                  <pub-id pub-id-type="doi">10.1002/pmic.201500067</pub-id>
                  <?supplied-pmid 25930030?>
                  <pub-id pub-id-type="pmid">25930030</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-ijms-16-26108">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thomas</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Bonchev</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>A survey of current software for network analysis in molecular biology</article-title>
                  <source>Hum. Genom.</source>
                  <year>2010</year>
                  <volume>4</volume>
                  <fpage>353</fpage>
                  <lpage>360</lpage>
                  <pub-id pub-id-type="doi">10.1186/1479-7364-4-5-353</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-ijms-16-26108">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chun</surname>
                      <given-names>M.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Serum signalling factors and spheroids</article-title>
                  <source>Crit. Rev. Oncol. Hematol.</source>
                  <year>2000</year>
                  <volume>36</volume>
                  <fpage>89</fpage>
                  <lpage>98</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1040-8428(00)00079-2</pub-id>
                  <pub-id pub-id-type="pmid">11033299</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-ijms-16-26108">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fiucci</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Ravid</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Reich</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Liscovitch</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells</article-title>
                  <source>Oncogene</source>
                  <year>2002</year>
                  <volume>21</volume>
                  <fpage>2365</fpage>
                  <lpage>2375</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.onc.1205300</pub-id>
                  <?supplied-pmid 11948420?>
                  <pub-id pub-id-type="pmid">11948420</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-ijms-16-26108">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Terada</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Urano</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Konno</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer</article-title>
                  <source>Eur. Surg. Res.</source>
                  <year>2005</year>
                  <volume>37</volume>
                  <fpage>166</fpage>
                  <lpage>172</lpage>
                  <pub-id pub-id-type="doi">10.1159/000085964</pub-id>
                  <?supplied-pmid 16088182?>
                  <pub-id pub-id-type="pmid">16088182</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-ijms-16-26108">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Provatopoulou</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Georgiadou</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Sergentanis</surname>
                      <given-names>T.N.</given-names>
                    </name>
                    <name>
                      <surname>Kalogera</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Spyridakis</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gounaris</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Zografos</surname>
                      <given-names>G.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Interleukins as markers of inflammation in malignant and benign thyroid disease</article-title>
                  <source>Inflamm. Res.</source>
                  <year>2014</year>
                  <volume>63</volume>
                  <fpage>667</fpage>
                  <lpage>674</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00011-014-0739-z</pub-id>
                  <?supplied-pmid 24794392?>
                  <pub-id pub-id-type="pmid">24794392</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-ijms-16-26108">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tuttled</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Fleisher</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Francis</surname>
                      <given-names>G.L.</given-names>
                    </name>
                    <name>
                      <surname>Robbins</surname>
                      <given-names>R.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2002</year>
                  <volume>87</volume>
                  <fpage>1737</fpage>
                  <lpage>1742</lpage>
                  <pub-id pub-id-type="doi">10.1210/jcem.87.4.8388</pub-id>
                  <?supplied-pmid 11932308?>
                  <pub-id pub-id-type="pmid">11932308</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-ijms-16-26108">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schoenberger</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Blockade of neoangiogenesis, a new and promising technique to control the growth of malignant tumors and their metastases</article-title>
                  <source>Curr. Vasc. Pharmacol.</source>
                  <year>2009</year>
                  <volume>7</volume>
                  <fpage>347</fpage>
                  <lpage>357</lpage>
                  <pub-id pub-id-type="doi">10.2174/157016109788340640</pub-id>
                  <?supplied-pmid 19601859?>
                  <pub-id pub-id-type="pmid">19601859</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-ijms-16-26108">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kristensen</surname>
                      <given-names>T.B.</given-names>
                    </name>
                    <name>
                      <surname>Knutsson</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Laursen</surname>
                      <given-names>B.E.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Magnusson</surname>
                      <given-names>N.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Anti-vascular endothelial growth factor therapy in breast cancer</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2014</year>
                  <volume>15</volume>
                  <fpage>23024</fpage>
                  <lpage>23041</lpage>
                  <pub-id pub-id-type="doi">10.3390/ijms151223024</pub-id>
                  <?supplied-pmid 25514409?>
                  <pub-id pub-id-type="pmid">25514409</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-ijms-16-26108">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Target-based anti-angiogenic therapy in breast cancer</article-title>
                  <source>Curr. Pharm. Des.</source>
                  <year>2012</year>
                  <volume>18</volume>
                  <fpage>4244</fpage>
                  <lpage>4257</lpage>
                  <pub-id pub-id-type="doi">10.2174/138161212802430468</pub-id>
                  <?supplied-pmid 22632607?>
                  <pub-id pub-id-type="pmid">22632607</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-ijms-16-26108">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marastoni</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ligresti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lorenzon</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Colombatti</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Mongiat</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Extracellular matrix: A matter of life and death</article-title>
                  <source>Connect. Tissue Res.</source>
                  <year>2008</year>
                  <volume>49</volume>
                  <fpage>203</fpage>
                  <lpage>206</lpage>
                  <pub-id pub-id-type="doi">10.1080/03008200802143190</pub-id>
                  <?supplied-pmid 18661343?>
                  <pub-id pub-id-type="pmid">18661343</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-ijms-16-26108">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chaudhary</surname>
                      <given-names>A.K.</given-names>
                    </name>
                    <name>
                      <surname>Pandya</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ghosh</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Nadkarni</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview</article-title>
                  <source>Rev. Mutat. Res.</source>
                  <year>2013</year>
                  <volume>753</volume>
                  <fpage>7</fpage>
                  <lpage>23</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mrrev.2013.01.002</pub-id>
                  <?supplied-pmid 23370482?>
                  <pub-id pub-id-type="pmid">23370482</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-ijms-16-26108">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kraiem</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Korem</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Matrix metalloproteinases and the thyroid</article-title>
                  <source>Thyroid</source>
                  <year>2000</year>
                  <volume>10</volume>
                  <fpage>1061</fpage>
                  <lpage>1069</lpage>
                  <pub-id pub-id-type="doi">10.1089/thy.2000.10.1061</pub-id>
                  <?supplied-pmid 11201850?>
                  <pub-id pub-id-type="pmid">11201850</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-ijms-16-26108">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pasieka</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Kuzdak</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Czyz</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Stepień</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Komorowski</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer</article-title>
                  <source>Neoplasma</source>
                  <year>2004</year>
                  <volume>51</volume>
                  <fpage>34</fpage>
                  <lpage>37</lpage>
                  <?supplied-pmid 15004657?>
                  <pub-id pub-id-type="pmid">15004657</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-ijms-16-26108">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tanaka</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Kurebayashi</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sohda</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Nomura</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Prabhakar</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Yan</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Sonoo</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence</article-title>
                  <source>Thyroid</source>
                  <year>2009</year>
                  <volume>19</volume>
                  <fpage>21</fpage>
                  <lpage>25</lpage>
                  <pub-id pub-id-type="doi">10.1089/thy.2008.0237</pub-id>
                  <?supplied-pmid 19072670?>
                  <pub-id pub-id-type="pmid">19072670</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-ijms-16-26108">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Menten</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Wuyts</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>van Damme</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Macrophage inflammatory protein-1</article-title>
                  <source>Cytokine Growth Factor Rev.</source>
                  <year>2002</year>
                  <volume>13</volume>
                  <fpage>455</fpage>
                  <lpage>481</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1359-6101(02)00045-X</pub-id>
                  <pub-id pub-id-type="pmid">12401480</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-ijms-16-26108">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Deshpande</surname>
                      <given-names>U.R.</given-names>
                    </name>
                    <name>
                      <surname>Nadkarni</surname>
                      <given-names>G.D.</given-names>
                    </name>
                    <name>
                      <surname>Samuel</surname>
                      <given-names>A.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Serum ferritin in thyroid cancer</article-title>
                  <source>Thyroid</source>
                  <year>1993</year>
                  <volume>3</volume>
                  <fpage>301</fpage>
                  <lpage>303</lpage>
                  <pub-id pub-id-type="doi">10.1089/thy.1993.3.301</pub-id>
                  <?supplied-pmid 8118224?>
                  <pub-id pub-id-type="pmid">8118224</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-ijms-16-26108">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>B.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Advancement of the study on iron metabolism and regulation in tumor cells</article-title>
                  <source>Chin. J. Cancer</source>
                  <year>2010</year>
                  <volume>29</volume>
                  <fpage>451</fpage>
                  <lpage>455</lpage>
                  <pub-id pub-id-type="doi">10.5732/cjc.009.10716</pub-id>
                  <?supplied-pmid 20346225?>
                  <pub-id pub-id-type="pmid">20346225</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-ijms-16-26108">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fan</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Dong</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Fan</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Discovery and identification of potential biomarkers of papillary thyroid carcinoma</article-title>
                  <source>Mol. Cancer</source>
                  <year>2009</year>
                  <volume>8</volume>
                  <fpage>79</fpage>
                  <lpage>83</lpage>
                  <pub-id pub-id-type="doi">10.1186/1476-4598-8-79</pub-id>
                  <?supplied-pmid 19785722?>
                  <pub-id pub-id-type="pmid">19785722</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-ijms-16-26108">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Laurent-Matha</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Huesgen</surname>
                      <given-names>P.F.</given-names>
                    </name>
                    <name>
                      <surname>Masson</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Derocq</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Prébois</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gary-Bobo</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Lecaille</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Rebière</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Meurice</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Oréar</surname>
                      <given-names>C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment</article-title>
                  <source>FASEB J.</source>
                  <year>2012</year>
                  <volume>26</volume>
                  <fpage>5172</fpage>
                  <lpage>5181</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.12-205229</pub-id>
                  <?supplied-pmid 22898924?>
                  <pub-id pub-id-type="pmid">22898924</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-ijms-16-26108">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nomura</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Zhau</surname>
                      <given-names>H.E.</given-names>
                    </name>
                    <name>
                      <surname>Josson</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Mimata</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>L.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>β2-Microglobulin-mediated signaling as a target for cancer therapy</article-title>
                  <source>Anticancer Agents Med. Chem.</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <fpage>343</fpage>
                  <lpage>352</lpage>
                  <pub-id pub-id-type="doi">10.2174/18715206113139990092</pub-id>
                  <?supplied-pmid 23848204?>
                  <pub-id pub-id-type="pmid">23848204</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-ijms-16-26108">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parmiani</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Castelli</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Pilla</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Santinami</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Colombo</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Rivoltini</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients</article-title>
                  <source>Ann. Oncol.</source>
                  <year>2007</year>
                  <volume>18</volume>
                  <fpage>226</fpage>
                  <lpage>232</lpage>
                  <pub-id pub-id-type="doi">10.1093/annonc/mdl158</pub-id>
                  <?supplied-pmid 17116643?>
                  <pub-id pub-id-type="pmid">17116643</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-ijms-16-26108">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Plow</surname>
                      <given-names>E.F.</given-names>
                    </name>
                    <name>
                      <surname>Herren</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Redlitz</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Miles</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Hoover-Plow</surname>
                      <given-names>J.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>The cell biology of the plasminogen system</article-title>
                  <source>FASEB J.</source>
                  <year>1995</year>
                  <volume>9</volume>
                  <fpage>939</fpage>
                  <lpage>945</lpage>
                  <?supplied-pmid 7615163?>
                  <pub-id pub-id-type="pmid">7615163</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-ijms-16-26108">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gonias</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Pizzo</surname>
                      <given-names>S.V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Reaction of human alpha2 macroglobulin half-molecules with plasmins as a probe of protease binding site structure</article-title>
                  <source>Biochemistry</source>
                  <year>1983</year>
                  <volume>22</volume>
                  <fpage>4933</fpage>
                  <lpage>4940</lpage>
                  <pub-id pub-id-type="doi">10.1021/bi00290a009</pub-id>
                  <?supplied-pmid 6196052?>
                  <pub-id pub-id-type="pmid">6196052</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-ijms-16-26108">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bendeck</surname>
                      <given-names>M.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Targeting pericellular proteolysis in vascular disease</article-title>
                  <source>Circ. Res.</source>
                  <year>2002</year>
                  <volume>91</volume>
                  <fpage>861</fpage>
                  <lpage>862</lpage>
                  <pub-id pub-id-type="doi">10.1161/01.RES.0000043396.97121.9C</pub-id>
                  <?supplied-pmid 12433829?>
                  <pub-id pub-id-type="pmid">12433829</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-ijms-16-26108">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Anderson</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Gragoire</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hegele</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Couture</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Marcini</surname>
                      <given-names>G.B.J.</given-names>
                    </name>
                    <name>
                      <surname>McPherson</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Francis</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Porier</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Lau</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>Grover</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>2012 update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult</article-title>
                  <source>Can. J. Cardiol.</source>
                  <year>2013</year>
                  <volume>29</volume>
                  <fpage>151</fpage>
                  <lpage>167</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cjca.2012.11.032</pub-id>
                  <?supplied-pmid 23351925?>
                  <pub-id pub-id-type="pmid">23351925</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-ijms-16-26108">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wewer</surname>
                      <given-names>U.M.</given-names>
                    </name>
                    <name>
                      <surname>Albrechtsen</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Tetranectin, a plasminogen Kringle 4-binding protein—Cloning and gene-expression pattern in human colon cancer</article-title>
                  <source>Lab. Investig.</source>
                  <year>1992</year>
                  <volume>67</volume>
                  <fpage>253</fpage>
                  <lpage>262</lpage>
                  <?supplied-pmid 1354271?>
                  <pub-id pub-id-type="pmid">1354271</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-ijms-16-26108">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mogues</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ezerodt</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hall</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Engelich</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Graversen</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Hartshorn</surname>
                      <given-names>K.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Tetranectin binds to the kringle 1–4 form of angiostatin and modifies its functional activity</article-title>
                  <source>J. Biomed. Biotechnol.</source>
                  <year>2004</year>
                  <volume>2</volume>
                  <fpage>73</fpage>
                  <lpage>78</lpage>
                  <pub-id pub-id-type="doi">10.1155/S1110724304307096</pub-id>
                  <?supplied-pmid 15240916?>
                  <pub-id pub-id-type="pmid">15240916</pub-id>
                </element-citation>
              </ref>
              <ref id="B52-ijms-16-26108">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Westergaard</surname>
                      <given-names>U.B.</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Heegaard</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Fedoson</surname>
                      <given-names>S.N.</given-names>
                    </name>
                    <name>
                      <surname>Peterson</surname>
                      <given-names>T.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Tetranectin binds to hepatocytes growth factor and tissue type plasminogen activator</article-title>
                  <source>Eur. J. Biochem.</source>
                  <year>2003</year>
                  <volume>270</volume>
                  <fpage>1850</fpage>
                  <lpage>1854</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1432-1033.2003.03549.x</pub-id>
                  <?supplied-pmid 12694198?>
                  <pub-id pub-id-type="pmid">12694198</pub-id>
                </element-citation>
              </ref>
              <ref id="B53-ijms-16-26108">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fan</surname>
                      <given-names>Z.Q.</given-names>
                    </name>
                    <name>
                      <surname>Larson</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Bognacki</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Raghunath</surname>
                      <given-names>P.N.</given-names>
                    </name>
                    <name>
                      <surname>Tomaszewski</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Kuo</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Canziani</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Chaiken</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Cines</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Higazi</surname>
                      <given-names>A.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Tissue factor regulates plasminogen binding and activation</article-title>
                  <source>Blood</source>
                  <year>1998</year>
                  <volume>91</volume>
                  <fpage>1987</fpage>
                  <lpage>1998</lpage>
                  <?supplied-pmid 9490681?>
                  <pub-id pub-id-type="pmid">9490681</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-ijms-16-26108">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ettelaie</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>James</surname>
                      <given-names>N.J.</given-names>
                    </name>
                    <name>
                      <surname>Adam</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Nicola</surname>
                      <given-names>K.P.</given-names>
                    </name>
                    <name>
                      <surname>Wilbourn</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Bruckdorfer</surname>
                      <given-names>K.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factor</article-title>
                  <source>Biochem. J.</source>
                  <year>1998</year>
                  <volume>333</volume>
                  <fpage>433</fpage>
                  <lpage>438</lpage>
                  <pub-id pub-id-type="doi">10.1042/bj3330433</pub-id>
                  <?supplied-pmid 9657985?>
                  <pub-id pub-id-type="pmid">9657985</pub-id>
                </element-citation>
              </ref>
              <ref id="B55-ijms-16-26108">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mandal</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Pendurthi</surname>
                      <given-names>U.R.</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>L.V.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cellular localization and trafficking of tissue factor</article-title>
                  <source>Blood</source>
                  <year>2006</year>
                  <volume>107</volume>
                  <fpage>4746</fpage>
                  <lpage>4753</lpage>
                  <pub-id pub-id-type="doi">10.1182/blood-2005-11-4674</pub-id>
                  <?supplied-pmid 16493004?>
                  <pub-id pub-id-type="pmid">16493004</pub-id>
                </element-citation>
              </ref>
              <ref id="B56-ijms-16-26108">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lupu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>X.H.</given-names>
                    </name>
                    <name>
                      <surname>Lupu</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2005</year>
                  <volume>280</volume>
                  <fpage>22308</fpage>
                  <lpage>22317</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M503333200</pub-id>
                  <?supplied-pmid 15817451?>
                  <pub-id pub-id-type="pmid">15817451</pub-id>
                </element-citation>
              </ref>
              <ref id="B57-ijms-16-26108">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shin</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ryu</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Chi</surname>
                      <given-names>S.G.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Caveolin-1 is associated with VCAM-1 dependent adhesion of gastric cancer cells to endothelial cells</article-title>
                  <source>Cell. Phys. Biochem.</source>
                  <year>2006</year>
                  <volume>17</volume>
                  <fpage>211</fpage>
                  <lpage>220</lpage>
                  <pub-id pub-id-type="doi">10.1159/000094126</pub-id>
                  <?supplied-pmid 16790997?>
                  <pub-id pub-id-type="pmid">16790997</pub-id>
                </element-citation>
              </ref>
              <ref id="B58-ijms-16-26108">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hill</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Daud</surname>
                      <given-names>N.H.</given-names>
                    </name>
                    <name>
                      <surname>Aung</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Loo</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Martin</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>D.M.</given-names>
                    </name>
                    <name>
                      <surname>Barry</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Simpson</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Co-Regulation of Cell Polarization and Migration by Caveolar Proteins PTRF/Cavin-1 and Caveolin-1</article-title>
                  <source>PLoS ONE</source>
                  <year>2012</year>
                  <volume>7</volume>
                  <fpage>e43041</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0043041</pub-id>
                  <?supplied-pmid 22912783?>
                  <pub-id pub-id-type="pmid">22912783</pub-id>
                </element-citation>
              </ref>
              <ref id="B59-ijms-16-26108">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pietsch</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sickmann</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Egli</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Wildgruber</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>A proteomic approach to analysing spheroid formation of two human thyroid cell lines cultured on a random positioning machine</article-title>
                  <source>Proteomics</source>
                  <year>2011</year>
                  <volume>10</volume>
                  <fpage>904</fpage>
                  <lpage>913</lpage>
                  <pub-id pub-id-type="doi">10.1002/pmic.201000817</pub-id>
                  <?supplied-pmid 21520503?>
                  <pub-id pub-id-type="pmid">20049858</pub-id>
                </element-citation>
              </ref>
              <ref id="B60-ijms-16-26108">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>S.W.</given-names>
                    </name>
                    <name>
                      <surname>Reimer</surname>
                      <given-names>C.L.</given-names>
                    </name>
                    <name>
                      <surname>Oh</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Campbell</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Schnitzer</surname>
                      <given-names>J.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells</article-title>
                  <source>Oncogene</source>
                  <year>1998</year>
                  <volume>16</volume>
                  <fpage>1391</fpage>
                  <lpage>1397</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.onc.1201661</pub-id>
                  <?supplied-pmid 9525738?>
                  <pub-id pub-id-type="pmid">9525738</pub-id>
                </element-citation>
              </ref>
              <ref id="B61-ijms-16-26108">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Racine</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Belanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hirabayashi</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Boucher</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Chakir</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Couet</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Reduction of caveolin 1 gene expression in lung carcinoma cell lines</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>1999</year>
                  <volume>255</volume>
                  <fpage>580</fpage>
                  <lpage>586</lpage>
                  <pub-id pub-id-type="doi">10.1006/bbrc.1999.0236</pub-id>
                  <?supplied-pmid 10049753?>
                  <pub-id pub-id-type="pmid">10049753</pub-id>
                </element-citation>
              </ref>
              <ref id="B62-ijms-16-26108">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wiechen</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Diatchenko</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Agoulnik</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Scharff</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Schober</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Arlt</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Zhumabayeva</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Siebert</surname>
                      <given-names>P.D.</given-names>
                    </name>
                    <name>
                      <surname>Dietel</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schafer</surname>
                      <given-names>R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene</article-title>
                  <source>Am. J. Pathol.</source>
                  <year>2001</year>
                  <volume>159</volume>
                  <fpage>1635</fpage>
                  <lpage>1643</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63010-6</pub-id>
                  <pub-id pub-id-type="pmid">11696424</pub-id>
                </element-citation>
              </ref>
              <ref id="B63-ijms-16-26108">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Engelman</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Wykoff</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Yashara</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Okamoto</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Lisante</surname>
                      <given-names>M.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>1997</year>
                  <volume>272</volume>
                  <fpage>16374</fpage>
                  <lpage>16381</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.272.26.16374</pub-id>
                  <?supplied-pmid 9195944?>
                  <pub-id pub-id-type="pmid">9195944</pub-id>
                </element-citation>
              </ref>
              <ref id="B64-ijms-16-26108">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rajjayabun</surname>
                      <given-names>P.H.</given-names>
                    </name>
                    <name>
                      <surname>Garg</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Durkan</surname>
                      <given-names>G.C.</given-names>
                    </name>
                    <name>
                      <surname>Charlton</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Robinson</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Mellon</surname>
                      <given-names>J.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Caveolin-1 expression is associated with high-grade bladder cancer</article-title>
                  <source>Urology</source>
                  <year>2001</year>
                  <volume>58</volume>
                  <fpage>811</fpage>
                  <lpage>814</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0090-4295(01)01337-1</pub-id>
                  <pub-id pub-id-type="pmid">11711373</pub-id>
                </element-citation>
              </ref>
              <ref id="B65-ijms-16-26108">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rimessi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Marchi</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Patergnani</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Pinton</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>H-ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling</article-title>
                  <source>Oncogene</source>
                  <year>2014</year>
                  <volume>33</volume>
                  <fpage>2329</fpage>
                  <lpage>2340</lpage>
                  <pub-id pub-id-type="doi">10.1038/onc.2013.192</pub-id>
                  <?supplied-pmid 23728347?>
                  <pub-id pub-id-type="pmid">23728347</pub-id>
                </element-citation>
              </ref>
              <ref id="B66-ijms-16-26108">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rimessi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Rizzuto</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Pinton</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Differential recruitment of pkc isoforms in hela cells during redox stress</article-title>
                  <source>Cell Stress Chaperones</source>
                  <year>2007</year>
                  <volume>12</volume>
                  <fpage>291</fpage>
                  <lpage>298</lpage>
                  <pub-id pub-id-type="doi">10.1379/CSC-211.1</pub-id>
                  <?supplied-pmid 18229448?>
                  <pub-id pub-id-type="pmid">18229448</pub-id>
                </element-citation>
              </ref>
              <ref id="B67-ijms-16-26108">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oka</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Yamamoto</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schwencke</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Kawabe</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ebina</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ohno</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Couet</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Lisanti</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Ishikawa</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>1997</year>
                  <volume>272</volume>
                  <fpage>33416</fpage>
                  <lpage>33421</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.272.52.33416</pub-id>
                  <?supplied-pmid 9407137?>
                  <pub-id pub-id-type="pmid">9407137</pub-id>
                </element-citation>
              </ref>
              <ref id="B68-ijms-16-26108">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yeh</surname>
                      <given-names>Y.C.</given-names>
                    </name>
                    <name>
                      <surname>Tanf</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Parekh</surname>
                      <given-names>A.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Caveolin-1 alters the pattern of cytoplasmic Ca<sup>2+</sup> oscillation and Ca<sup>2+</sup>-dependent gene expression by enhancing leukotriene receptor desensitization</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2014</year>
                  <volume>289</volume>
                  <fpage>17843</fpage>
                  <lpage>17853</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M114.553453</pub-id>
                  <?supplied-pmid 24755228?>
                  <pub-id pub-id-type="pmid">24755228</pub-id>
                </element-citation>
              </ref>
              <ref id="B69-ijms-16-26108">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>Q.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ca<sup>2+</sup> oscillation frequency regulates agonist-stimulated gene expression in vascular endothelial cells</article-title>
                  <source>J. Cell Sci.</source>
                  <year>2008</year>
                  <volume>121</volume>
                  <fpage>2511</fpage>
                  <lpage>2518</lpage>
                  <pub-id pub-id-type="doi">10.1242/jcs.031997</pub-id>
                  <?supplied-pmid 18628303?>
                  <pub-id pub-id-type="pmid">18628303</pub-id>
                </element-citation>
              </ref>
              <ref id="B70-ijms-16-26108">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Warnke</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Aleshcheva</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Magnusson</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity</article-title>
                  <source>Sci. Rep.</source>
                  <year>2015</year>
                  <volume>5</volume>
                  <fpage>16691</fpage>
                  <pub-id pub-id-type="doi">10.1038/srep16691</pub-id>
                  <?supplied-pmid 26576504?>
                  <pub-id pub-id-type="pmid">26576504</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
